Alpha 2.0
Login Register
» Authors » Yolanda Torres

Yolanda Torres

Explore the profile of Yolanda Torres including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 50
Citations 2040
Followers 0
Related Specialties
Psychiatry
Public Health
Social Sciences
Top 10 Co-Authors
Ronald C Kessler
Jose Posada-Villa
Fernando Navarro-Mateu
Elie G Karam
Oye Gureje
Jordi Alonso
Sing Lee
Giovanni de Girolamo
Josep Maria Haro
Marina Piazza
Published In
JAMA Psychiatry
Psychol Med
J Affect Disord
World Psychiatry
Depress Anxiety
Affiliations
Soon will be listed here.
Recent Articles
1.
The case for eliminating excessive worry as a requirement for generalized anxiety disorder: a cross-national investigation
Ruscio A, Rassaby M, Stein M, Stein D, Aguilar-Gaxiola S, Al-Hamzawi A, et al.
Psychol Med . 2024 Oct; :1-12. PMID: 39364896
Background: Around the world, people living in objectively difficult circumstances who experience symptoms of generalized anxiety disorder (GAD) do not qualify for a diagnosis because their worry is not 'excessive'...
2.
Crystal structure of (1,4,7,10,13,16-hexa-oxa-cycloocta-decane-κ )potassium-μ-oxalato-tri-phenylstannate(IV), the first reported 18-crown-6-stabilized potassium salt of tri-phenyl-oxalatostannate
Song X, Li W, Torres Y, Greaves T
Acta Crystallogr E Crystallogr Commun . 2024 Sep; 80(Pt 9):951-955. PMID: 39267864
The title complex, (1,4,7,10,13,16-hexa-oxa-cyclo-octa-decane-1κ )(μ-oxalato-1κ , :2κ , )triphenyl-2κ -potassium(I)tin(IV), [KSn(CH)(CO)(CHO)] or K[18-Crown-6][(CH)SnOC], was synthesized. The complex consists of a potassium cation coordinated to the six oxygen atoms of a...
3.
Patterns, predictors, and patient-reported reasons for antidepressant discontinuation in the WHO World Mental Health Surveys
Kazdin A, Harris M, Hwang I, Sampson N, Stein D, Viana M, et al.
Psychol Med . 2023 Sep; 54(1):67-78. PMID: 37706298
Background: Despite their documented efficacy, substantial proportions of patients discontinue antidepressant medication (ADM) without a doctor's recommendation. The current report integrates data on patient-reported reasons into an investigation of patterns...
4.
Age of onset and cumulative risk of mental disorders: a cross-national analysis of population surveys from 29 countries
McGrath J, Al-Hamzawi A, Alonso J, Altwaijri Y, Andrade L, Bromet E, et al.
Lancet Psychiatry . 2023 Aug; 10(9):668-681. PMID: 37531964
Background: Information on the frequency and timing of mental disorder onsets across the lifespan is of fundamental importance for public health planning. Broad, cross-national estimates of this information from coordinated...
5.
Findings From the World Mental Health Surveys of Civil Violence Exposure and Its Association With Subsequent Onset and Persistence of Mental Disorders
Axinn W, Bruffaerts R, Kessler T, Frounfelker R, Aguilar-Gaxiola S, Alonso J, et al.
JAMA Netw Open . 2023 Jun; 6(6):e2318919. PMID: 37338903
Importance: Understanding the association of civil violence with mental disorders is important for developing effective postconflict recovery policies. Objective: To estimate the association between exposure to civil violence and the...
6.
The associations between traumatic experiences and subsequent onset of a substance use disorder: Findings from the World Health Organization World Mental Health surveys
Degenhardt L, Bharat C, Glantz M, Bromet E, Alonso J, Bruffaerts R, et al.
Drug Alcohol Depend . 2022 Sep; 240:109574. PMID: 36150948
Aim: Exposure to traumatic events (TEs) is associated with substance use disorders (SUDs). However, most studies focus on a single TE, and are limited to single countries, rather than across...
7.
Increased risks for mental disorders among LGB individuals: cross-national evidence from the World Mental Health Surveys
Gmelin J, de Vries Y, Baams L, Aguilar-Gaxiola S, Alonso J, Borges G, et al.
Soc Psychiatry Psychiatr Epidemiol . 2022 Jul; 57(11):2319-2332. PMID: 35851652
Purpose: Lesbian, gay, and bisexual (LGB) individuals, and LB women specifically, have an increased risk for psychiatric morbidity, theorized to result from stigma-based discrimination. To date, no study has investigated...
8.
Patterns and correlates of patient-reported helpfulness of treatment for common mental and substance use disorders in the WHO World Mental Health Surveys
Kessler R, Kazdin A, Aguilar-Gaxiola S, Al-Hamzawi A, Alonso J, Altwaijri Y, et al.
World Psychiatry . 2022 May; 21(2):272-286. PMID: 35524618
Patient-reported helpfulness of treatment is an important indicator of quality in patient-centered care. We examined its pathways and predictors among respondents to household surveys who reported ever receiving treatment for...
9.
Perceived helpfulness of treatment for social anxiety disorder: findings from the WHO World Mental Health Surveys
Bruffaerts R, Harris M, Kazdin A, Vigo D, Sampson N, Chiu W, et al.
Soc Psychiatry Psychiatr Epidemiol . 2022 Mar; 57(10):2079-2095. PMID: 35262761
Purpose: To investigate the prevalence and predictors of perceived helpfulness of treatment in persons with a history of DSM-IV social anxiety disorder (SAD), using a worldwide population-based sample. Methods: The...
10.
Barriers to treatment for mental disorders in six countries of the Americas: A regional report from the World Mental Health Surveys
Orozco R, Vigo D, Benjet C, Borges G, Aguilar-Gaxiola S, Andrade L, et al.
J Affect Disord . 2022 Feb; 303:273-285. PMID: 35176342
Background: Mental health treatment is scarce and little resources are invested in reducing the wide treatment gap that exists in the Americas. The regional barriers are unknown. We describe the...